Clinical Trials
3 trialsNCT07467629 2026-05-19
QLS5212 for Participants With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07584954 2026-05-13
Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
ImmunoUrchin
Phase 1 Recruiting
NCT07492173 2026-03-25
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Shandong New Time Pharmaceutical Co., LTD
Phase NA Completed